Medical Devices

COPD Drugs Market in China 2016-2020

  • TEC612767
  • 74 Pages
  • June 2016
  • Medical Devices
About the Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China

Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not understood, but most cases are caused due to genetic factors and by inhaling pollutants, including smoke, fumes, and chemicals. As the disease develops, the symptoms tend to get worse and damages the lungs. The disease cannot be cured, and can only be managed and treated.

The COPD drugs market in China is under penetrated. It is dominated by fixed dose combinations of LABA/ICS. Air pollution is the major contributing factor for the growing prevalence of the disease. Nearly 10% of the population in the region who are over the age of 40 years has COPD. The disease is expected to become one of the leading causes of death in the country by 2020. Lack of awareness about the disease and its treatment options affects the growth of the market in this region.

Technavios analysts forecast the chronic obstructive pulmonary disease drugs market in China to grow at a CAGR of 15.56% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the chronic obstructive pulmonary disease drugs market in China for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of the chronic obstructive pulmonary disease drugs globally. The report does not include revenue generated from the aftermarket service of the product.

The market is divided into the following segments based on drug class:
Bronchodilators
Phosphodiesterase-4 (PDE-4) inhibitors
Steroids
Combination therapies

Technavio's report, Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.

Key vendors
AstraZeneca
Boehringer Ingelheim
GSK
Merck
Novartis
Other prominent vendors
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
BioMarck Pharmaceuticals
Gilead Sciences
Mereo BioPharma Group
Mylan
Orion
Pearl Therapeutics
Prosonix
Teva Pharmaceutical Industry
Theravance Biopharma
Theron Pharmaceuticals
Verona Pharma
Xention
ZAI Lab

Market driver
Increase in environmental pollution
For a full, detailed list, view our report

Market challenge
Low diagnosis rate
For a full, detailed list, view our report

Market trend
Increased focus on combination therapies
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.




Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Medical Ultrasound Devices Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Medical ultrasound devices use high frequency sound waves to visualize soft tissues such as tendons or internal organs. Ultrasound devices uses sound waves with frequencies that are higher than those ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Ablation Devices Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Ablation is minimal invasion technique which involves removal of malfunctioning tissues either by surgery, chemicals or by radiofrequency. It is used in various treatments such as cancers, atrial fibrillation, cosmetology, ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Patient Monitoring Devices Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Patient’s monitors include all kinds which are being used to track the vital signs of patients, in medical devices, used as monitoring devices, helps to communicate and integrate the information ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Transplant Diagnostics Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Transplantation is the process of relocating organ in order to treat organ failure such as lungs, heart, pancreas, liver and kidney. Human leukocyte antigens (HLA) are the major histocompatibility complex ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Catheter Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Medical catheters are used in healthcare to deliver medications or to drain bodily fluids. They can be inserted into a body cavity, duct or blood vessel. Catheters play an important ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>